JPH09510738A - 禁酒及びヌートロピック効果を付与された医薬組成物 - Google Patents

禁酒及びヌートロピック効果を付与された医薬組成物

Info

Publication number
JPH09510738A
JPH09510738A JP8521587A JP52158796A JPH09510738A JP H09510738 A JPH09510738 A JP H09510738A JP 8521587 A JP8521587 A JP 8521587A JP 52158796 A JP52158796 A JP 52158796A JP H09510738 A JPH09510738 A JP H09510738A
Authority
JP
Japan
Prior art keywords
composition
pharmaceutical composition
alcohol
present
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8521587A
Other languages
English (en)
Japanese (ja)
Inventor
アレクスィーフナ コミスサロバ，イリナ
バシリーフナ グドコーバ，ユリア
ドミトリエフナ ソルダテンコーバ，タティアナ
ティホノフナ コンドラショバ，タティアナ
ミハイロフナ ブルベンスカヤ，ナタルヤ
Original Assignee
アレクスィーフナ コミスサロバ，イリナ
バシリーフナ グドコーバ，ユリア
ドミトリエフナ ソルダテンコーバ，タティアナ
ティホノフナ コンドラショバ，タティアナ
ミハイロフナ ブルベンスカヤ，ナタルヤ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アレクスィーフナ コミスサロバ，イリナ, バシリーフナ グドコーバ，ユリア, ドミトリエフナ ソルダテンコーバ，タティアナ, ティホノフナ コンドラショバ，タティアナ, ミハイロフナ ブルベンスカヤ，ナタルヤ filed Critical アレクスィーフナ コミスサロバ，イリナ
Priority claimed from FR9608205A external-priority patent/FR2750605B1/fr
Publication of JPH09510738A publication Critical patent/JPH09510738A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP8521587A 1995-01-13 1996-01-04 禁酒及びヌートロピック効果を付与された医薬組成物 Pending JPH09510738A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
RU95100307 1995-01-13
RU9595100307A RU2097034C1 (ru) 1995-01-13 1995-01-13 Фармацевтический препарат антиалкогольного и ноотропного действия
PCT/RU1996/000006 WO1996021446A1 (fr) 1995-01-13 1996-01-04 Composition pharmaceutique a proprietes antialcooliques et nootropes
DE19626431A DE19626431B4 (de) 1995-01-13 1996-07-01 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung
FR9608205A FR2750605B1 (fr) 1995-01-13 1996-07-02 Composition pharmaceutique a effets antialcooliques et nootropes
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Publications (1)

Publication Number Publication Date
JPH09510738A true JPH09510738A (ja) 1997-10-28

Family

ID=27428256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8521587A Pending JPH09510738A (ja) 1995-01-13 1996-01-04 禁酒及びヌートロピック効果を付与された医薬組成物

Country Status (5)

Country Link
JP (1) JPH09510738A (ru)
CH (1) CH691791A8 (ru)
DE (1) DE19626431B4 (ru)
RU (1) RU2097034C1 (ru)
WO (1) WO1996021446A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018127427A (ja) * 2017-02-10 2018-08-16 味の素株式会社 唾液分泌促進剤、ならびにこれを配合した食品組成物、および口腔用組成物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия
FR2750605B1 (fr) * 1995-01-13 1998-09-25 Komissarova Irina Alexeevna Composition pharmaceutique a effets antialcooliques et nootropes
RU2561063C1 (ru) * 2014-07-01 2015-08-20 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") Способ коррекции неврологических нарушений при хронической алкогольной интоксикации

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4761429A (en) * 1985-07-22 1988-08-02 Kenneth Blum Enkephalinase and endorphinase inhibitors as anti-craving compositions
US5019558A (en) * 1988-05-09 1991-05-28 Georges Cehovic Method for treating memory disturbances using arginine aspartate
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
JP3162709B2 (ja) * 1992-01-10 2001-05-08 アレクセエフナ コミッサロバ，イリナ 抗ストレス、ストレス予防性及び向神経性作用の医薬調製物
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018127427A (ja) * 2017-02-10 2018-08-16 味の素株式会社 唾液分泌促進剤、ならびにこれを配合した食品組成物、および口腔用組成物

Also Published As

Publication number Publication date
RU2097034C1 (ru) 1997-11-27
DE19626431B4 (de) 2011-03-17
CH691791A5 (de) 2001-10-31
DE19626431A1 (de) 1998-01-08
CH691791A8 (de) 2002-03-15
WO1996021446A1 (fr) 1996-07-18

Similar Documents

Publication Publication Date Title
US8962042B2 (en) Methods for treating neurological disorders using nutrient compositions
US11957725B2 (en) Methods for treating neurological disorders using nutrient compositions
CA2859066C (en) Ellagitannins rich extracts composition
KR20090003148A (ko) 나이와 관련된 기억 손상의 치료를 위한 케톤 생성조성물의 용도
US5262162A (en) Cerebral-activating extract
JPH09510738A (ja) 禁酒及びヌートロピック効果を付与された医薬組成物
Spies Some recent advances in nutrition
Brady et al. Diabetes
US5798371A (en) Pharmaceutical composition endowed with an antialcoholic and nootropic effect
Marcus 10 Simple Solutions to Migraines: Recognize Triggers, Control Symptoms, and Reclaim Your Life
Schilling Marijuana Causes Schizophrenia and Heart Attacks
Foreyt Control of overeating by aversion therapy
Lolli Alcoholism as a medical problem
TW202304484A (zh) 用於改善睡眠品質之組合物
Webb Medical Meanderings
Learner et al. The Magnesium Miracle
Rodriguez et al. The Diabetes Solution: How to Control Type 2 Diabetes and Reverse Prediabetes Using Simple Diet and Lifestyle Changes--with 100 Recipes
Simpson The women's guide to thyroid health: comprehensive solutions for all your thyroid symptoms
Clyne Birth Weight and Maternal Smoking
Vukovic User's Guide to Chronic Fatigue and Fibromyalgia
FR2750605A1 (fr) Composition pharmaceutique a effets antialcooliques et nootropes
DiSano Holistic mental health: A comparison of traditional and alternative treatments for mental disorders
Applebaum Effects of caffeine ingestion during tobacco withdrawal
Reid INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
Bankova Life Manual for Graves' Disease and Hyperthyroidism

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060915

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061030

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070227